Transcriptional regulation of CCL20 expression

Microbes and Infection

Volumn 16, Issue 10, 2014, Pages 864-870

  Zhao, Lifang ^a   Xia, Jingyan ^a   Wang, Xiangdong ^b   Xu, Feng ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

CCL20; CCR6; Transcriptional regulation

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1; CCL20 PROTEIN, HUMAN; PROTEIN BINDING;

ARTICLE; B LYMPHOCYTE; BINDING SITE; CANCER CELL; CD4+ T LYMPHOCYTE; CELL MIGRATION; DENDRITIC CELL; EFFECTOR CELL; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLAMMATORY DISEASE; LEUKOCYTE; MEMORY T LYMPHOCYTE; METASTASIS; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; ANIMAL; DISEASE MODEL; GENETICS; METABOLISM; TUMOR CELL LINE; UPREGULATION;

ANIMALS; B-LYMPHOCYTES; BINDING SITES; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE, TUMOR; CHEMOKINE CCL20; DISEASE MODELS, ANIMAL; HUMANS; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; UP-REGULATION;

EID: 84927630294     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2014.08.005     Document Type: Article

References (46)

1. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in . Immunity 2000, 12:121-127.
2. Yoshie O. Immune chemokines and their receptors: the key elements in the genesis, homeostasis and function of the immune system. Springer Semin Immunopathol 2000, 22:371-391.
3. Ansel K.M., Cyster J.G. Chemokines in lymphopoiesis and lymphoid organ development. Curr Opin Immunol 2001, 13:172-179.
4. Baba M., Imai T., Nishimura M., Kakizaki M., Takagi S., Hieshima K., et al. Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J Biol Chem 1997, 272:14893-14898.
5. Kaser A., Ludwiczek O., Holzmann S., Moschen A.R., Weiss G., Enrich B., et al. Increased expression of CCL20 in human inflammatory bowel disease. J Clin Immunol 2004, 24:74-85.
6. Hirota K., Yoshitomi H., Hashimoto M., Maeda S., Teradaira S., Sugimoto N., et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 2007, 204:2803-2812.
7. Yamazaki T., Yang X.O., Chung Y., Fukunaga A., Nurieva R., Pappu B., et al. CCR6 regulates the migration of inflammatory and regulatory T cells. J Immunol 2008, 181:8391-8401.
8. Comerford I., Bunting M., Fenix K., Haylock-Jacobs S., Litchfield W., Harata-Lee Y., et al. An immune paradox: how can the same chemokine axis regulate both immune tolerance and activation?: CCR6/CCL20: a chemokine axis balancing immunological tolerance and inflammation in autoimmune disease. Bioessays 2010, 32:1067-1076.
9. Du D., Liu Y., Qian H., Zhang B., Tang X., Zhang T., et al. The effects of the CCR6/CCL20 biological axis on the invasion and metastasis of hepatocellular carcinoma. Int J Mol Sci 2014, 15:6441-6452.
10. Ito M., Teshima K., Ikeda S., Kitadate A., Watanabe A., Nara M., et al. MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma. Blood 2014, 123:1499-1511.
11. Cheng X.S., Li Y.F., Tan J., Sun B., Xiao Y.C., Fang X.B., et al. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition. Cancer Lett 2014, 348:77-87.
12. Li J., Lindstrom L.S., Foo J.N., Rafiq S., Schmidt M.K., Pharoah P.D., et al. 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy. Nat Commun 2014, 5:4051.
13. Hieshima K., Imai T., Opdenakker G., Van Damme J., Kusuda J., Tei H., et al. Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J Biol Chem 1997, 272:5846-5853.
14. Rossi D.L., Vicari A.P., Franz-Bacon K., McClanahan T.K., Zlotnik A. Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3alpha and MIP-3beta. J Immunol 1997, 158:1033-1036.
15. Hromas R., Gray P.W., Chantry D., Godiska R., Krathwohl M., Fife K., et al. Cloning and characterization of exodus, a novel beta-chemokine. Blood 1997, 89:3315-3322.
16. Nelson R.T., Boyd J., Gladue R.P., Paradis T., Thomas R., Cunningham A.C., et al. Genomic organization of the CC chemokine mip-3alpha/CCL20/larc/exodus/SCYA20, showing gene structure, splice variants, and chromosome localization. Genomics 2001, 73:28-37.
17. Sugita S., Kohno T., Yamamoto K., Imaizumi Y., Nakajima H., Ishimaru T., et al. Induction of macrophage-inflammatory protein-3alpha gene expression by TNF-dependent NF-kappaB activation. J Immunol 2002, 168:5621-5628.
18. Kwon J.H., Keates S., Simeonidis S., Grall F., Libermann T.A., Keates A.C. ESE-1, an enterocyte-specific Ets transcription factor, regulates MIP-3alpha gene expression in Caco-2 human colonic epithelial cells. J Biol Chem 2003, 278:875-884.
19. Schutyser E., Struyf S., Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 2003, 14:409-426.
20. Yu M., Hu J., Zhu M.X., Zhao T., Liang W., Wen S., et al. Cardiac fibroblasts recruit Th17 cells infiltration into myocardium by secreting CCL20 in CVB3-induced acute viral myocarditis. Cell Physiol Biochem 2013, 32:1437-1450.
21. Ito T., Carson W.T., Cavassani K.A., Connett J.M., Kunkel S.L. CCR6 as a mediator of immunity in the lung and gut. Exp Cell Res 2011, 317:613-619.
22. Baeuerle P.A., Baltimore D. Nf-κB: ten years after. Cell 1996, 87:13-20.
23. Hoffmann A., Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol Rev 2006, 210:171-186.
24. Harant H., Eldershaw S.A., Lindley I.J. Human macrophage inflammatory protein-3alpha/CCL20/LARC/Exodus/SCYA20 is transcriptionally upregulated by tumor necrosis factor-alpha via a non-standard NF-kappaB site. Febs Lett 2001, 509:439-445.
25. Fujiie S., Hieshima K., Izawa D., Nakayama T., Fujisawa R., Ohyanagi H., et al. Proinflammatory cytokines induce liver and activation-regulated chemokine/macrophage inflammatory protein-3alpha/CCL20 in mucosal epithelial cells through NF-kappaB [correction of NK-kappaB]. Int Immunol 2001, 13:1255-1263.
26. Miao H., Zhang Y., Lu Z., Yu L., Gan L. FOXO1 increases CCL20 to promote NF-kappaB-dependent lymphocyte chemotaxis. Mol Endocrinol 2012, 26:423-437.
27. Ma X., Reynolds S.L., Baker B.J., Li X., Benveniste E.N., Qin H. IL-17 enhancement of the IL-6 signaling cascade in astrocytes. J Immunol 2010, 184:4898-4906.
28. Ambrosini E., Columba-Cabezas S., Serafini B., Muscella A., Aloisi F. Astrocytes are the major intracerebral source of macrophage inflammatory protein-3alpha/CCL20 in relapsing experimental autoimmune encephalomyelitis and invitro. Glia 2003, 41:290-300.
29. Meares G.P., Ma X., Qin H., Benveniste E.N. Regulation of CCL20 expression in astrocytes by IL-6 and IL-17. Glia 2012, 60:771-781.
30. Li R., Xu W., Chen Y., Qiu W., Shu Y., Wu A., et al. Raloxifene suppresses experimental autoimmune encephalomyelitis and NF-kappaB-dependent CCL20 expression in reactive astrocytes. PLoS One 2014, 9:e94320.
31. Calvayrac O., Rodriguez-Calvo R., Alonso J., Orbe J., Martin-Ventura J.L., Guadall A., et al. CCL20 is increased in hypercholesterolemic subjects and is upregulated by LDL in vascular smooth muscle cells: role of NF-kappaB. Arterioscler Thromb Vasc Biol 2011, 31:2733-2741.
32. Kanda N., Shibata S., Tada Y., Nashiro K., Tamaki K., Watanabe S. Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes. Eur J Immunol 2009, 39:996-1006.
33. Li X., Syrovets T., Simmet T. The serine protease plasmin triggers expression of the CC-chemokine ligand 20 in dendritic cells via Akt/NF-kappaB-dependent pathways. J Biomed Biotechnol 2012, 2012:186710.
34. Sirard J.C., Didierlaurent A., Cayet D., Sierro F., Rumbo M. Toll-like receptor 5- and lymphotoxin beta receptor-dependent epithelial Ccl20 expression involves the same NF-kappaB binding site but distinct NF-kappaB pathways and dynamics. Biochim Biophys Acta 2009, 1789:386-394.
35. Chang L.H., Huang H.S., Wu P.T., Jou I.M., Pan M.H., Chang W.C., et al. Role of macrophage CCAAT/enhancer binding protein delta in the pathogenesis of rheumatoid arthritis in collagen-induced arthritic mice. PLoS One 2012, 7:e45378.
36. Sperling T., Oldak M., Walch-Ruckheim B., Wickenhauser C., Doorbar J., Pfister H., et al. Human papillomavirus type 8 interferes with a novel C/EBPbeta-mediated mechanism of keratinocyte CCL20 chemokine expression and Langerhans cell migration. PLoS Pathog 2012, 8:e1002833.
37. Mukherjee R., Jow L., Croston G.E., Paterniti J.J. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists. J Biol Chem 1997, 272:8071-8076.
38. Qi W., Chen X., Zhang Y., Holian J., Mreich E., Gilbert R.E., et al. High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism. Nephrol Dial Transpl 2007, 22:3147-3153.
39. Qi W., Holian J., Tan C.Y., Kelly D.J., Chen X.M., Pollock C.A. The roles of Kruppel-like factor 6 and peroxisome proliferator-activated receptor-gamma in the regulation of macrophage inflammatory protein-3alpha at early onset of diabetes. Int J Biochem Cell Biol 2011, 43:383-392.
40. Homey B., Dieu-Nosjean M.C., Wiesenborn A., Massacrier C., Pin J.J., Oldham E., et al. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 2000, 164:6621-6632.
41. Huang C., Pollock C.A., Chen X.M. High glucose induces CCL20 in proximal tubular cells via activation of the KCa3.1 channel. PLoS One 2014, 9:e95173.
42. Woltman A.M., de Fijter J.W., van der Kooij S.W., Jie K.E., Massacrier C., Caux C., et al. MIP-3alpha/CCL20 in renal transplantation and its possible involvement as dendritic cell chemoattractant in allograft rejection. Am J Transpl 2005, 5:2114-2125.
43. Turner J.E., Paust H.J., Steinmetz O.M., Peters A., Riedel J.H., Erhardt A., et al. CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis. J Am Soc Nephrol 2010, 21:974-985.
44. Esplugues E., Huber S., Gagliani N., Hauser A.E., Town T., Wan Y.Y., et al. Control of TH17 cells occurs in the small intestine. Nature 2011, 475:514-518.
45. Frick V.O., Rubie C., Kolsch K., Wagner M., Ghadjar P., Graeber S., et al. CCR6/CCL20 chemokine expression profile in distinct colorectal malignancies. Scand J Immunol 2013, 78:298-305.
46. Affo S., Morales-Ibanez O., Rodrigo-Torres D., Altamirano J., Blaya D., Dapito D.H., et al. CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis. Gut 2014 Jan 10, [Epub ahead of print]. 10.1136/gutjnl-2013-306098.